News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
502,385 Results
Type
Article (37468)
Company Profile (96)
Press Release (464821)
Multimedia
Podcasts (59)
Webinars (7)
Section
Business (146069)
Career Advice (1871)
Deals (28327)
Drug Delivery (109)
Drug Development (69389)
Employer Resources (123)
FDA (11904)
Job Trends (11042)
News (260565)
Policy (28040)
Tag
Academia (2152)
Academic (1)
Accelerated approval (5)
Adcomms (23)
Allergies (81)
Alliances (44861)
ALS (83)
Alzheimer's disease (1293)
Antibody-drug conjugate (ADC) (162)
Approvals (11889)
Artificial intelligence (241)
Autoimmune disease (27)
Automation (14)
Bankruptcy (261)
Best Places to Work (9219)
BIOSECURE Act (16)
Biosimilars (109)
Biotechnology (69)
Bladder cancer (80)
Brain cancer (29)
Breast cancer (284)
Cancer (2214)
Cardiovascular disease (164)
Career advice (1543)
Career pathing (25)
CAR-T (138)
Cell therapy (394)
Cervical cancer (22)
Clinical research (56518)
Collaboration (829)
Company closure (2)
Compensation (576)
Complete response letters (22)
COVID-19 (2629)
CRISPR (42)
C-suite (181)
Cystic fibrosis (75)
Data (2123)
Decentralized trials (1)
Denatured (10)
Depression (47)
Diabetes (261)
Diagnostics (4731)
Digital health (14)
Diversity (4)
Diversity, equity & inclusion (35)
Drug discovery (111)
Drug pricing (111)
Drug shortages (28)
Duchenne muscular dystrophy (99)
Earnings (64109)
Editorial (41)
Employer branding (17)
Employer resources (110)
Events (69591)
Executive appointments (555)
FDA (13108)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (661)
Gene editing (96)
Generative AI (19)
Gene therapy (297)
GLP-1 (783)
Government (4366)
Grass and pollen (5)
Guidances (152)
Healthcare (14369)
Huntington's disease (21)
IgA nephropathy (29)
Immunology and inflammation (136)
Indications (25)
Infectious disease (2783)
Inflammatory bowel disease (129)
Inflation Reduction Act (8)
Influenza (56)
Intellectual property (88)
Interviews (332)
IPO (13332)
IRA (46)
Job creations (2257)
Job search strategy (1329)
Kidney cancer (8)
Labor market (34)
Layoffs (375)
Leadership (14)
Legal (7509)
Liver cancer (72)
Lung cancer (320)
Lymphoma (146)
Machine learning (8)
Management (38)
Manufacturing (294)
MASH (80)
Medical device (8696)
Medtech (8697)
Mergers & acquisitions (15548)
Metabolic disorders (715)
Multiple sclerosis (78)
NASH (21)
Neurodegenerative disease (95)
Neuropsychiatric disorders (29)
Neuroscience (1806)
NextGen: Class of 2025 (4781)
Non-profit (3418)
Now hiring (13)
Obesity (391)
Opinion (215)
Ovarian cancer (69)
Pain (81)
Pancreatic cancer (80)
Parkinson's disease (138)
Partnered (14)
Patents (200)
Patient recruitment (89)
Peanut (42)
People (31367)
Pharmaceutical (24)
Pharmacy benefit managers (13)
Phase I (17377)
Phase II (24722)
Phase III (19354)
Pipeline (1317)
Policy (152)
Postmarket research (2131)
Preclinical (7190)
Press Release (50)
Prostate cancer (101)
Psychedelics (34)
Radiopharmaceuticals (226)
Rare diseases (344)
Real estate (3354)
Recruiting (52)
Regulatory (18253)
Reports (33)
Research institute (1909)
Resumes & cover letters (300)
Rett syndrome (6)
RNA editing (3)
RSV (50)
Schizophrenia (71)
Series A (113)
Series B (67)
Service/supplier (6)
Sickle cell disease (50)
Special edition (15)
Spinal muscular atrophy (144)
Sponsored (24)
Startups (2386)
State (1)
Stomach cancer (16)
Supply chain (69)
Tariffs (42)
The Weekly (48)
Vaccines (777)
Venture capitalists (33)
Weight loss (279)
Women's health (18)
Worklife (14)
Date
Today (62)
Last 7 days (881)
Last 30 days (2696)
Last 365 days (28056)
2025 (10515)
2024 (29237)
2023 (31692)
2022 (40971)
2021 (43936)
2020 (42119)
2019 (35356)
2018 (26533)
2017 (25214)
2016 (23362)
2015 (27102)
2014 (20500)
2013 (16672)
2012 (17566)
2011 (18271)
2010 (16618)
Location
Africa (692)
Alabama (44)
Alaska (4)
Arizona (131)
Arkansas (8)
Asia (31595)
Australia (5486)
California (5467)
Canada (1664)
China (504)
Colorado (220)
Connecticut (240)
Delaware (149)
Europe (75118)
Florida (773)
Georgia (162)
Hawaii (1)
Idaho (34)
Illinois (434)
India (24)
Indiana (242)
Iowa (9)
Japan (164)
Kansas (77)
Kentucky (21)
Louisiana (12)
Maine (45)
Maryland (837)
Massachusetts (4091)
Michigan (146)
Minnesota (266)
Mississippi (2)
Missouri (63)
Montana (25)
Nebraska (13)
Nevada (55)
New Hampshire (55)
New Jersey (1549)
New Mexico (19)
New York (1532)
North Carolina (731)
North Dakota (6)
Northern California (2445)
Ohio (163)
Oklahoma (10)
Oregon (21)
Pennsylvania (1131)
Puerto Rico (9)
Rhode Island (21)
South America (967)
South Carolina (15)
South Dakota (1)
Southern California (2068)
Tennessee (72)
Texas (744)
United States (19819)
Utah (126)
Virginia (122)
Washington D.C. (52)
Washington State (474)
West Virginia (3)
Wisconsin (56)
502,385 Results for "4 antibody ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Opinion
Bringing Neurological Disease Into the Age of Precision Medicine
To more effectively treat neurodegenerative conditions, we first need diagnostic tools that lend a more complete picture of protein aggregates in the brain.
May 12, 2025
·
5 min read
·
John McDonough
Press Releases
Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology
April 7, 2025
·
4 min read
Press Releases
Precision Biologics to Present Recent Data on a New Antibody-Drug Conjugate (ADC) Utilizing the Monoclonal Antibody (mAb) PB-223, at AACR Annual Meeting 2025
April 25, 2025
·
5 min read
Press Releases
DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development
February 13, 2025
·
1 min read
Press Releases
CStone Presents the Latest Preclinical Findings of CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) at 2025 AACR
May 6, 2025
·
5 min read
Press Releases
CVS Health Foundation grants $4 million as part of its new healthy aging initiative
January 23, 2025
·
7 min read
Press Releases
ProBio to Present Data on Its CD3 Agonistic Single Domain Antibody Platform for Accelerated Development of T Cell Engager Multi-Specific Antibodies
April 14, 2025
·
3 min read
Business
Araris Biotech AG Appoints Dr. Ulf Grawunder to Scientific Advisory Board
Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate - technology, announced the appointment of Ulf Grawunder, Ph.D. to its scientific advisory board.
June 13, 2024
·
3 min read
Press Releases
AGC Biologics Partners with Novelty Nobility for Cell Line Development and Phase I Preparations of Antibody Drug Candidate
May 6, 2025
·
4 min read
Deals
Araris Biotech AG Acquires ARS Pharmaceutical’s Nectin-4 Antibody
Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, today announced the execution of an asset purchase agreement for the acquisition of ARS Pharmaceutical’s Nectin-4 antibody.
April 17, 2023
·
2 min read
1 of 50,239
Next
